Federal Register / Vol. 72, No.
13 / Monday, January 22, 2007 / Notices
Date: February 5–6, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Double Tree Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Paul A. Amstad, PhD,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, National Institutes of Health/
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC–7616, Bethesda, MD 20892–7616, 301–
402–7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transportation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–250 Filed 1–19–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Library of Medicine; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Library of
Medicine Special Emphasis Panel, G08/R21.
Date: February 16, 2007.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Bethesda Suites, 6711
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Zoe E. Huang, MD, Health
Science Administrator, Extramural Programs,
National Library of Medicine, NIH, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20892–7968, 301–594–4937,
rmajette on PROD1PC67 with NOTICES
huangz@mail.nih.gov.
Name of Committee: National Library of
Medicine Special Emphasis Panel, Scholarly
Works (G13).
Date: February 28, 2007.
Time: 9 a.m. to 4:30 p.m.
VerDate Aug<31>2005 15:20 Jan 19, 2007 Jkt 211001
2705
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Zoe E. Huang, MD, Health
Science Administrator, Extramural Programs,
National Library of Medicine, NIH, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20892–7968, 301–594–4937,
huangz@mail.nih.gov.
Name of Committee: National Library of
Medicine Special Emphasis Panel, R01/R03/
R13.
Date: March 2, 2007.
Time: 8:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hills
Road, Bethesda, MD 20814.
Contact Person: Zoe E. Huang, MD, Health
Science Administrator, Extramural Programs,
National Library of Medicine, NIH, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20892–7968, 301–594–4937,
huangz@mail.nih.gov.
Name of Committee: National Library of
Medicine Special Emphasis Panel, Loan
Repayment Program (L30/L40).
Date: April 25, 2007.
Time: 1:30 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Library of Medicine, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Zoe E. Huang, MD, Health
Science Administrator, Extramural Programs,
National Library of Medicine, NIH, 6705
Rockledge Drive, Suite 301, Bethesda, MD
20892–7968, 301–594–4937,
huangz@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.879, Medical Library
Assistance, National Institutes of Health,
HHS)
Dated: January 11, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–237 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of Biotechnology Activities,
Office of Science Policy, Office of the
Director; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following meeting
of the National Science Advisory Board
for Biosecurity (NSABB).
Under authority 42 U.S.C. 217a,
section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\22JAN1.SGM
NSABB to provide advice, guidance and
leadership regarding Federal oversight
of dual-use research, defined as
biological research with legitimate
scientific purposes that could be
misused to pose a biological threat to
public health and/or national security.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(1), Title 5 U.S.C., as amended
because matters sensitive to the interest
of national security will be presented.
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: January 31, 2007.
Time: 9 a.m. to 3 p.m.
Agenda: Representatives from the
Intelligence Community will present a
classified session on the current
counterterrorism and couterproliferation
threats to the U.S.
Place: At a predetermined location in
Virginia.
Contact Person: Ronna Hill, NSABB
Program Assistant, NIH Office of
Biotechnology Activities, 6705 Rockledge
Drive, Bethesda, Maryland 20892, (301) 496–
9838.
This meeting is being published less than
15 days prior to the meeting due to timing
limitations imposed by administrative
matters.
Dated: January 12, 2007.
David Clary,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 07–240 Filed 1–19–07; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in section 552b(c)(4)
and 552b(c)(6), Title 5 U.S.C., as
amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Oncological Sciences
Integrated Review Group, Radiation
Therapeutics and Biology Study Section.
Date: January 29–30, 2007.
22JAN1